Seagal Teitz-Tennenbaum

Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy.

Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration.

Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines.

Radiation-induced apoptosis along with local and systemic cytokine elaboration is associated with DC plus radiotherapy-mediated renal cell tumor regression.

4-1BB costimulation of effector T cells for adoptive immunotherapy of cancer: involvement of Bcl gene family members.

Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy.

Interleukin-21 augments the efficacy of T-cell therapy by eliciting concurrent cellular and humoral responses.

Intratumoral dendritic cells and chemoradiation for the treatment of murine squamous cell carcinoma.

Dendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma model.

Radiotherapy combined with intratumoral dendritic cell vaccination enhances the therapeutic efficacy of adoptive T-cell transfer.

In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy.

Serum autoantibody profiling using a natural glycoprotein microarray for the prognosis of early melanoma.

DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen.

Cancer stem cell vaccination confers significant antitumor immunity.

Targeting cancer stem cells via dendritic-cell vaccination.

Murine colitis is mediated by vimentin.

Effects of tumor irradiation on host T-regulatory cells and systemic immunity in the context of adoptive T-cell therapy in mice.